EPISODE · Jan 8, 2025 · 1 MIN
AbbVie Leads Injectables Boom Towards $19 Billion by 2029
from AI Automation Minute · host Dr. Teri Fisher
This episode explores the rapidly expanding world of facial injectables, projected to reach nearly $19 billion by 2029. Driven by a trend towards non-invasive beauty solutions and an aging population, the sector has seen significant contributions from key players like AbbVie and Evolus. The podcast discusses market dynamics, such as the prominence of dermal fillers and Botulinum toxin, while also addressing the challenges of adverse effects and regulations faced by the industry. Additionally, it highlights future advancements, including AI and digital tools, that promise to transform aesthetic treatments. Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare: 🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher📲 Follow on Instagram for automation tips: @DrTeriFisher💡 Discover AI tools for your practice: DrTeriFisher.com🎙 Listen to the long-form podcast: Anti-Aging Insights 👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder! #AIAutomationMinute #DrTeriFisher #HealthcareAI
Embed this episode
What this episode covers
This episode explores the rapidly expanding world of facial injectables, projected to reach nearly $19 billion by 2029. Driven by a trend towards non-invasive beauty solutions and an aging population, the sector has seen significant contributions from key players like AbbVie and Evolus. The podcast discusses market dynamics, such as the prominence of dermal fillers and Botulinum toxin, while also addressing the challenges of adverse effects and regulations faced by the industry. Additionally,...
NOW PLAYING
AbbVie Leads Injectables Boom Towards $19 Billion by 2029
No transcript for this episode yet
Similar Episodes
No similar episodes found.